RZLT (Rezolute) Beta: 2.0434 (As of Aug. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RZLT Rezolute Inc RZLT
34 GF Score
Price $5.09
! 1 Warning Sign
View Full Analysis

What is Rezolute Beta?

Rezolute RZLT +9.11% 34 Beta is 2.0434 as of Aug. 24, 2026. GuruFocus rates RZLT with a GF Score™ of 34/100. The stock has 1 warning sign investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-24), Rezolute's Beta is 2.0434.


Rezolute  (NAS:RZLT) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Rezolute Beta Related Terms


Rezolute Beta Historical Data

* Premium members only.

The historical data trend for Rezolute's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rezolute Beta Chart

Rezolute Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.95 1.84 0.53 0.23 0.55

Rezolute Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.55 0.89 2.45 2.40

RZLT vs DNA, EIKN, ARTV: Beta Comparison

For the Biotechnology subindustry, Rezolute's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rezolute Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rezolute's Beta distribution charts can be found below:

* The bar in red indicates where Rezolute's Beta falls into.


RZLT
34GF Score
Rezolute Inc RZLT
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rezolute Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 2.0434 mean?
Rezolute (RZLT) has a Beta of 2.0434 as of Aug. 24, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Rezolute and its competitors.
Is Rezolute's Beta too high?
Rezolute's current Beta is 2.0434. Overall, Rezolute has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Rezolute's Beta compare to DNA and EIKN?
Rezolute's Beta of 2.0434 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Rezolute and its competitors. Rezolute's current Beta is 2.0434. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rezolute stock overvalued right now?
Rezolute (RZLT) has a current Beta of 2.0434. The current Beta is 2.0434. Rezolute's overall GF Score™ is 34/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Rezolute (RZLT), the current Beta is 2.0434 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rezolute Business Description

Address 275 Shoreline Drive, Suite 500, Redwood City, CA, USA, 94065
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
34GF Score

Get the complete analysis for RZLT

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.09
Price